Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet
Jun 27, 2026
View online
Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet
China Approves Satri-cel, the World’s First CAR-T Therapy for Solid Tumors
Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits
Key Insights from ASCO Breakthrough 2026 with Julie Gralow
FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC
Merck KGaA’s $11.3 Billion Bet on Bio-Techne Redraws the Map of Life-Science Tools
25 Posts Not To Miss from MASCC 2026
Speed and Rigor Are Not in Conflict – Garo Armen
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
